REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 4.68 Billion by 2030 | 5.16% | North America |
by Type | by Species | by End User |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Pet Stem Cells Market Overview
The global pet stem cells market is anticipated to grow from USD 3.29 Billion in 2023 to USD 4.68 Billion by 2030, at a CAGR of 5.16% during the forecast period.
Pet stem cells, known as undifferentiated cells, possess the ability to transform into various cell types within animals. These cells are found in various tissues including fat, umbilical cord blood, and bone marrow. Utilizing stem cells in pet stem cell therapy facilitates the rejuvenation and restoration of impaired animal tissues. This form of treatment is applicable to address diverse conditions like inflammatory bowel disease, hip dysplasia, ligament and tendon injuries, as well as arthritis. Although pet stem cell treatment is a young subject, clinical experiments have showed promise. For instance, one study discovered that osteoarthritis-affected dogs receiving stem cell treatment experienced reduced discomfort and improved joint function.
The firms focus on moving towards animal stem cell treatments in order to raise the prevalence of sickness in animals and improve the animals’ quality of life. Animal stem cell treatment is also expanding as a result of the government providing more funds for animal welfare and the FDA approving therapies quickly. The study of animal stem cells has enormous potential for revealing the underlying principles governing animal growth and for treating a variety of ailments that affect animals. The importance of this therapy as a translational paradigm for treating human disease is becoming more widely acknowledged. All of these element’s work as catalysts for the industry for animal stem cell treatment to expand rapidly.
Animal stem cell therapy involves employing an animal’s stem cells to address a particular health condition. Stem cells possess the ability to divide and transform into various cell types, each contributing to the restoration of damaged bodily tissues caused by ailments. The three phases of the animal stem cell treatment procedure include gathering animal stem cell samples and organizing the samples to concentrate the stem cells. Finally, the treatment is injecting the stem cells into the injured area to treat it. Animals receiving this treatment live longer and experience fewer negative effects. It can be used to treat arthritis, tendon and ligament injuries, and degenerative joint diseases in animals. Animals including cats, dogs, and horses are frequently treated with stem cell treatment.
In companion animals, stem cell treatment to regenerate tissues can be used to treat osteoarthritis, degenerative joint disease, ligament injuries, and other orthopedic problems. Growing pet ownership and public knowledge of the advantages of regenerative medicine for animals are driving market expansion. In order to help with tissue repair and regeneration, stem cells are extracted from adipose tissue, bone marrow, or other sources and processed before being administered to dogs. Despite its promise, pet stem cell treatments are not as widely used as they may be due to issues including high treatment costs, low pet owner knowledge, and regulatory issues.
ATTRIBUTE | DETAILS |
Study period | 2020-2030 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2030 |
Historical period | 2019-2021 |
Unit | Value (USD Billion) |
Segmentation | By Type, By Species, By End User, and By Region |
By Type |
|
By Species |
|
By End User |
|
By Region
 |
|
Pet Stem Cells Market Segmentation Analysis
The global pet stem cells market is divided into 4 segments type, species, end user and region. Based on type, the pet stem cells market is classified into allogeneic and autologous. The pet stem cells market is categorized into dogs, cats, horse and others based on species. By end user, the market is divided into veterinary hospitals, veterinary clinics, research organizations.
Allogeneic stem cell therapy holds the maximum market share. Utilizing stem cells from an additional species is known as allogeneic stem cell therapy. Allogeneic stem cell treatment provides a number of advantages as compared to autologous stem cell transplantation. Allogeneic stem cells are initially more widely accessible. Second, a greater variety of animals can be treated using allogeneic stem cell treatment. Third, compared to autologous stem cell treatment, allogeneic stem cell therapy is frequently less costly. Considering it uses widely accessible stem cell products from a range of donors, allogeneic stem cell treatment is popular in the pet stem cells market because to its affordability and ease. This method shortens the length of the procedure, making it a popular choice and adding to its commanding market share.
Autologous stem cell therapy refers to using a pet’s own stem cells. As it is customized for each individual animal, this type of care may be more advantageous for specific conditions. Autologous stem cell treatment is more expensive and challenging to perform than allogeneic stem cell therapy. This approach has a lesser risk of rejection or adverse reactions because the stem cells are from the same animal. Treatments for a range of canine conditions, including arthritis, joint injuries, and even systemic illnesses, may be developed using these animal stem cells.
Due to the high incidence of degenerative conditions, such as arthritis and hip dysplasia, among dogs, they constitute the primary market for pet stem cell therapy. Dogs are the most treated species with pet stem cell therapy, given their widespread popularity as pets globally. This is attributed to the common occurrence of degenerative conditions like arthritis and hip dysplasia in canines. Dogs suffering from these conditions can experience reduced pain and inflammation, along with improved joint function, through pet stem cell treatment. Furthermore, the application of pet stem cell treatment has the potential to delay the onset of degenerative diseases and enhance the overall health of affected dogs.
Due to the increasing trend in cat adoption and the growing understanding of pet stem cell therapy by cat owners, cats represent the second-largest segment of the pet stem cell therapy market. Cats rank as the second most popular pets globally, contributing to the expanding market for this form of treatment in pets. The surge in cat ownership and the heightened awareness of pet stem cell therapy contribute to this growth. Pet stem cell treatment can effectively address various conditions in cats such as cancer, inflammatory bowel disease, arthritis, and hip dysplasia. By utilizing pet stem cell therapy, cats’ organ functions can be enhanced, discomfort and inflammation can be alleviated, and the progression of diseases can be delayed.
Pet Stem Cells Market Dynamics
Driver
The market for animal stem cell treatment is expected to rise as a result of increasing illness prevalence in the world’s expanding animal population.
The growing frequency of ailments among the expanding global animal population bodes well for the future expansion of the market for animal stem cell therapies. The need for cutting-edge treatment alternatives like stem cell therapy is growing as more animal’s struggle with a variety of health issues, including degenerative joint illnesses, traumas, and chronic ailments. In ageing dogs or those with few other therapeutic options, stem cell therapy provides a remarkable promise for regeneration and healing. Additionally, pet owners and veterinarians are exploring cutting-edge therapies like stem cell treatments because to the rising knowledge and acceptance of regenerative medicine in veterinary care. This market’s growth is further fueled by the need to increase dogs’ lifespan and quality of life. The creation of increasingly effective and specialized therapies is also being aided by continuous research and technology developments in stem cell therapy, which are piquing investor interest and customer interest. However, in order to assure universal accessibility and affordability of animal stem cell therapies, issues including high treatment costs and regulatory considerations must be resolved.
Restraint
The industry’s future development prospects will be negatively impacted by the high costs of animal stem cell therapy procedures.
The high costs connected with these procedures may limit the industry’s future growth and development possibilities for animal stem cell treatment. The high cost of animal stem cell treatment is a key obstacle to its broad adoption. The cost of these cutting-edge therapies is sometimes prohibitive for pet owners, which restricts accessibility and prevents market growth. The market cannot reach a wider audience due to how expensive stem cell treatment operations are, especially in areas with little financial means. Further increasing the cost burden on pet owners and decreasing their inclination to choose stem cell therapy is the absence of comprehensive insurance coverage for such treatments. For improving affordability and broadening the market, efforts must be made to solve and offset these cost issues through research, technical breakthroughs, and simplifying manufacturing techniques. Collaboration amongst industry participants can assist ease the financial strain on pet owners and spur the market for animal stem cell therapy in the future by creating cost-effective alternatives and advocating for enhanced insurance coverage.
Opportunities
Pet owners’ growing propensity to choose treatments with minimal side effects presents the industry with appealing prospects.
The industry’s future is looking very promising because to pet owners’ growing preference for therapies with less negative effects. Pet owners’ priorities the health and quality of life of their animals, so they look for treatments that are safe and have few side effects. This desire fits nicely with stem cell treatment due to its low risk and less intrusive nature. Pet owners looking for the best results for their animals are drawn to it because of its ability to provide focused and efficient therapy while minimizing damage to healthy tissues. Furthermore, the growing public knowledge of and education about developments in veterinary care contributes to this trend towards safer treatment alternatives. More pet owners are anticipated to choose stem cell therapies as consumer confidence in these treatments rises, fueling demand and industry expansion. In order to capitalize on this trend and fulfil the expectations of discriminating pet owners looking for the finest possible care for their animal companions, continued research and development efforts to improve the safety and efficacy of stem cell treatments will be crucial.
Pet Stem Cells Market Trends
-
Allogeneic stem cell treatment, a form of stem cell therapy that employs stem cells from another species, is in increasing demand. Compared to autologous stem cell treatment, which employs the pet’s own stem cells, this sort of therapy is more accessible and effective for treating a larger variety of animals.
-
Creation of novel stem cell sources: Researchers are creating new stem cell sources, like as umbilical cord blood and adipose tissue, for use in pet stem cell treatment. These new resources may increase pet owners’ access to and affordability of stem cell treatment.
-
Targeted stem cell therapy development: New targeted stem cell treatments are being created by researchers that can selectively target sick or injured tissues in animals. This could result in stem cell treatments that are less intrusive and more successful.
-
Combination therapy development: New combination therapies are being created by researchers that combine gene and medication therapy with stem cell therapy. This could result in more efficient and beneficial therapies for a larger variety of pet illnesses.
-
Regenerative medicine is a profession that is expanding that employs stem cells to heal or replace damaged tissues in animals. Regenerative medicine for pets is in high demand. A form of regenerative medicine, pet stem cell treatment is becoming more and more popular as degenerative disorders in pets become more common.
Competitive Landscape
The competitive landscape in the pet stem cells market is dynamic and evolving, driven by factors such as technological advancements, healthcare infrastructure development, and the increasing demand for flexible and efficient pet care solutions. Key players in this market include established manufacturers, emerging companies, and niche players, each striving to gain a competitive edge.
- Vet-Stem
- Stemedica Cell Technologies
- Stem Cell Therapeutics
- Vet Regen
- Animal Regenerative Medicine International (ARMI)
- Mesoblast
- Regenexxcell
- Cell Therapy Sciences
- Stem Cell Applications
- Celltex Therapeutics
- Cytori Therapeutics
- VetCell Technologies
- Stem Cells International
- VetCell Bioscience
- Stemedica Cell Technologies
- Cell Therapy Group
- Osiris Therapeutics
- Humacyte
- Anteris Technologies
- Biostage
Â
Recent Developments:
August 22, 2023 – With the introduction of their brand-new off-the-shelf PRP solution, leading regenerative veterinary medicine business VetStem, Inc. revolutionised the way platelet-rich plasma is administered to patients. Leucoreduced, allogeneic, pooled, and freeze-dried platelet-rich plasma (PRP) is known as PrecisePRPTM, and it is designed to offer a species-specific supply of concentrated platelets in plasma for intra-articular delivery in dogs and horses.
May 24, 2021 – A San Diego-based biotech company called Stemedica Cell Technologies, Inc. that produces clinical-grade stem cells has announced that it has signed a licencing agreement with Pulthera, LLC to use, sell, and distribute its mesenchymal stem cell technologies to treat COVID-19 and other pulmonary diseases.
Regional Analysis
North America accounted for the largest market in the pet stem cells market. North America accounted for the 40% market share of the global market value. It has a sizable market share in North America due to the strong demand for treatment. Due to the enormous number of pet owners and the increased government financing for animal health, which is reviving the industry, animal stem cell treatment is in great demand in North America. The market for pet stem cells is growing in North America because to the increased need for innovative veterinary treatments. Dogs in the neighborhood may have better lives thanks to stem cell therapy, especially those with age-related and orthopedic conditions. This awareness is growing among pet owners. Favorable governmental actions and financial commitments to R&D can support market expansion.
The market for pet stem cells in Europe is expanding quickly and has a lot of promise. The market was expanding significantly, propelled by increased pet owners’ knowledge of the advantages of stem cell treatment and a rising propensity for cutting-edge veterinary care. The market was growing as a result of the area’s developed veterinary infrastructure, favorable regulatory climate, and continuous research initiatives. Advancements in the sector were also being facilitated through partnerships between academic institutions, business leaders, and veterinary experts.
Target Audience for Pet Stem Cells
- Veterinarians and Veterinary Clinics
- Pet Owners
- Pet Healthcare Providers
- Veterinary Hospitals and Research Institutions
- Pet Health Insurance Companies
- Pharmaceutical and Biotechnology Companies
- Regulatory Authorities and Policymakers
- Animal Health Organizations
- Academic and Research Institutions
- Investors and Venture Capitalists
Segments Covered in the Pet Stem Cells Market Report
 Pet Stem Cells Market by Type
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
 Pet Stem Cells Market by Species
- Dogs
- Cats
- Horses
- Other Animals
Pet Stem Cells Market by End User
- Veterinary Hospitals
- Veterinary Clinics
- Research Organizations
 Pet Stem Cells Market by Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Â
Key Question Answered
- What is the expected growth rate of the pet stem cells market over the next 7 years?
- Who are the major players in the pet stem cells market and what is their market share?
- What are the end-user industries driving market demand and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-pacific, the middle east, and Africa?
- How is the economic environment affecting the pet stem cells market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the pet stem cells market?
- What is the current and forecasted size and growth rate of the global pet stem cells market?
- What are the key drivers of growth in the Pet Stem Cells market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the pet stem cells market?
- What are the technological advancements and innovations in the pet stem cells market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the pet stem cells market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the pet stem cells market?
- What are the product products and specifications of leading players in the market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- PET STEM CELLS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON PET STEM CELLS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- PET STEM CELLS MARKET OUTLOOK
- GLOBAL PET STEM CELLS MARKET BY TYPE, 2020-2030, (USD BILLION)
- ALLOGENEIC STEM CELL THERAPY
- AUTOLOGOUS STEM CELL THERAPY
- GLOBAL PET STEM CELLS MARKET BY SPECIES, 2020-2030, (USD BILLION)
- DOGS
- CATS
- HORSES
- OTHER ANIMALS
- GLOBAL PET STEM CELLS MARKET BY END USER, 2020-2030, (USD BILLION)
- VETERINARY HOSPITALS
- VETERINARY CLINICS
- RESEARCH ORGANIZATIONS
- GLOBAL PET STEM CELLS MARKET BY REGION, 2020-2030, (USD BILLION)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- VET-STEM
- STEMEDICA CELL TECHNOLOGIES
- STEM CELL THERAPEUTICS
- VET REGEN
- ANIMAL REGENERATIVE MEDICINE INTERNATIONAL (ARMI)
- MESOBLAST
- REGENEXXCELL
- CELL THERAPY SCIENCES
- STEM CELL APPLICATIONS
- CELLTEX THERAPEUTICS
- CYTORI THERAPEUTICS
- VETCELL TECHNOLOGIES
- STEM CELLS INTERNATIONAL
- VETCELL BIOSCIENCE
- STEMEDICA CELL TECHNOLOGIES
- CELL THERAPY GROUP
- OSIRIS THERAPEUTICS
- HUMACYTE
- ANTERIS TECHNOLOGIES
- BIOSTAGEÂ Â Â Â Â Â Â Â *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 2 GLOBAL PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 3 GLOBAL PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 4 GLOBAL PET STEM CELLS MARKET BY REGIONS (USD BILLION) 2020-2030
TABLE 5 NORTH AMERICA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 6 NORTH AMERICA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 7 NORTH AMERICA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 8 NORTH AMERICA PET STEM CELLS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 9 US PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 10 US PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 11 US PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 12 CANADA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 13 CANADA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 14 CANADA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 15 MEXICO PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 16 MEXICO PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 17 MEXICO PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 18 SOUTH AMERICA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 19 SOUTH AMERICA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 20 SOUTH AMERICA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 21 SOUTH AMERICA PET STEM CELLS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 22 BRAZIL PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 23 BRAZIL PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 24 BRAZIL PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 25 ARGENTINA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 26 ARGENTINA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 27 ARGENTINA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 28 COLOMBIA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 29 COLOMBIA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 30 COLOMBIA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 31 REST OF SOUTH AMERICA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 32 REST OF SOUTH AMERICA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 33 REST OF SOUTH AMERICA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 34 ASIA-PACIFIC PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 35 ASIA-PACIFIC PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 36 ASIA-PACIFIC PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 37 ASIA-PACIFIC PET STEM CELLS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 38 INDIA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 39 INDIA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 40 INDIA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 41 CHINA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 42 CHINA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 43 CHINA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 44 JAPAN PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 45 JAPAN PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 46 JAPAN PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 47 SOUTH KOREA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 48 SOUTH KOREA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 49 SOUTH KOREA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 50 AUSTRALIA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 51 AUSTRALIA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 52 AUSTRALIA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 53 SOUTH-EAST ASIA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 54 SOUTH-EAST ASIA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 55 SOUTH-EAST ASIA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 56 REST OF ASIA PACIFIC PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 57 REST OF ASIA PACIFIC PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 58 REST OF ASIA PACIFIC PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 59 EUROPE PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 60 EUROPE PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 61 EUROPE PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 62 EUROPE PET STEM CELLS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 63 GERMANY PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 64 GERMANY PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 65 GERMANY PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 66 UK PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 67 UK PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 68 UK PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 69 FRANCE PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 70 FRANCE PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 71 FRANCE PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 72 ITALY PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 73 ITALY PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 74 ITALY PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 75 SPAIN PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 76 SPAIN PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 77 SPAIN PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 78 RUSSIA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 79 RUSSIA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 80 RUSSIA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 81 REST OF EUROPE PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 82 REST OF EUROPE PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 83 REST OF EUROPE PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 84 MIDDLE EAST AND AFRICA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 85 MIDDLE EAST AND AFRICA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 86 MIDDLE EAST AND AFRICA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 87 MIDDLE EAST AND AFRICA PET STEM CELLS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 88 UAE PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 89 UAE PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 90 UAE PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 91 SAUDI ARABIA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 92 SAUDI ARABIA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 93 SAUDI ARABIA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 94 SOUTH AFRICA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 95 SOUTH AFRICA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 96 SOUTH AFRICA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 97 REST OF MIDDLE EAST AND AFRICA PET STEM CELLS MARKET BY TYPE (USD BILLION) 2020-2030
TABLE 98 REST OF MIDDLE EAST AND AFRICA PET STEM CELLS MARKET BY SPECIES (USD BILLION) 2020-2030
TABLE 99 REST OF MIDDLE EAST AND AFRICA PET STEM CELLS MARKET BY END USER (USD BILLION) 2020-2030
Â
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL PET STEM CELLS MARKET BY TYPE USD BILLION, 2020-2030
FIGURE 9 GLOBAL PET STEM CELLS MARKET BY SPECIES USD BILLION, 2020-2030
FIGURE 10 GLOBAL PET STEM CELLS MARKET BY END USER USD BILLION, 2020-2030
FIGURE 11 GLOBAL PET STEM CELLS MARKET BY REGION USD BILLION, 2020-2030
FIGURE 12 PORTER’S FIVE FORCES MODEL
FIGURE 13 GLOBAL PET STEM CELLS MARKET BY TYPE USD BILLION, 2022
FIGURE 14 GLOBAL PET STEM CELLS MARKET BY SPECIES USD BILLION, 2022
FIGURE 15 GLOBAL PET STEM CELLS MARKET BY END USER USD BILLION, 2022
FIGURE 16 GLOBAL PET STEM CELLS MARKET BY REGION USD BILLION, 2022
FIGURE 17 MARKET SHARE ANALYSIS
FIGURE 18 VET-STEM: COMPANY SNAPSHOT
FIGURE 19 STEMEDICA CELL TECHNOLOGIES: COMPANY SNAPSHOT
FIGURE 20 STEM CELL THERAPEUTICS: COMPANY SNAPSHOT
FIGURE 21 VET REGEN: COMPANY SNAPSHOT
FIGURE 22 ANIMAL REGENERATIVE MEDICINE INTERNATIONAL (ARMI): COMPANY SNAPSHOT
FIGURE 23 MESOBLAST: COMPANY SNAPSHOT
FIGURE 24 REGENEXXCELL: COMPANY SNAPSHOT
FIGURE 25 CELL THERAPY SCIENCES: COMPANY SNAPSHOT
FIGURE 26 STEM CELL APPLICATIONS: COMPANY SNAPSHOT
FIGURE 27 CELLTEX THERAPEUTICS: COMPANY SNAPSHOT
FIGURE 28 CYTORI THERAPEUTICS: COMPANY SNAPSHOT
FIGURE 29 VETCELL TECHNOLOGIES: COMPANY SNAPSHOT
FIGURE 30 STEM CELLS INTERNATIONAL: COMPANY SNAPSHOT
FIGURE 31 VETCELL BIOSCIENCE: COMPANY SNAPSHOT
FIGURE 32 STEMEDICA CELL TECHNOLOGIES: COMPANY SNAPSHOT
FIGURE 33 CELL THERAPY GROUP: COMPANY SNAPSHOT
FIGURE 34 OSIRIS THERAPEUTICS: COMPANY SNAPSHOT
FIGURE 35 HUMACYTE: COMPANY SNAPSHOT
FIGURE 36 ANTERIS TECHNOLOGIES: COMPANY SNAPSHOT
FIGURE 37 BIOSTAGE: COMPANY SNAPSHOT
FAQ
The global pet stem cells market is anticipated to grow from USD 3.29 Billion in 2023 to USD 4.68 Billion by 2030, at a CAGR of 5.16% during the forecast period.
North America accounted for the largest market in the pet stem cells market. North America accounted for 40% market share of the global market value.
Vet-Stem, Stemedica Cell Technologies, Stem Cell Therapeutics, Vet Regen, Animal Regenerative Medicine International (ARMI), Mesoblast, Regenexxcell, Cell Therapy Sciences, Stem Cell Applications, Celltex Therapeutics, Cytori Therapeutics, VetCell Technologies, Stem Cells International, VetCell Bioscience, Stemedica Cell Technologies, Cell Therapy Group, Osiris Therapeutics, Humacyte, Anteris Technologies, Biostage
Creation of novel stem cell sources: Researchers are creating new stem cell sources, like as umbilical cord blood and adipose tissue, for use in pet stem cell treatment. These new resources may increase pet owners’ access to and affordability of stem cell treatment.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.